Biotechnology in South Korea

Geninus Inc

Big Data Analytics in Genomics.

51 to 200 staff

Lsk Global Ps

LSK Global Pharma Services Co, Ltd.(LSK Global PS) is a leading clinical trial-conducting Contract Research Organization (CRO) in South Korea, with experience in every aspect of Korea's clinical research history."A CRO that Embraces Accountability Grounded in competence and Honesty, CRO." Blog(KR): https://blog.naver.com/lskglobalpsblog

201 to 500 staff

Sartorius Korea Biotech

150 - A joint venture with Sartorius - a German company on a 150 years journey of bioprocessing innovations - and has offered the clients trusted, proven R&D, pre-clinical, fermentation, cell culture, purification, clarification, and filtration solutions, and more. With these solutions built on its robust integrated base technologies, Sartorius enables the biopharmaceutical clients to develop biosimilars like therapeutic antibiotics and biologics like vaccines as safely and promptly, with economic feasibility.#SimplifyProgress

201 to 500 staff

Inocras Inc

Inocras is a bioinformatics-led company redefining precision health through whole genome data and proprietary analytics. Our oncology and rare disease platforms integrate comprehensive whole genome data with advanced automation to deliver curated and actionable insights at scale. These capabilities deliver curated, actionable insights that accelerate discovery and diagnostics to improve patient care, bringing a real-world impact. We operate a CLIA/CAP-certified laboratory and partners with leading hospitals, pharmaceutical companies, and research institutions worldwide.

11 to 50 staff

Wells Bio

WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. In this day and age, where the importance of early diagnosis and treatment have been on the rise due to the aging population and globalization of illnesses, WELLS BIO pursues to be the world’s life-caring companion to all mankind.

51 to 200 staff

Koreabio

KoreaBIO, a leading organization in the bioindustry encompassing pharmaceuticals, medical devices, environmental technology, biotechnology, and more, supports the business endeavours of over 600 member companies of various sizes across all sectors of the bioindustry, including red, white, and green. Its mission is to vitalize the Korean bio-industry ecosystem.

11 to 50 staff

Advanced Protein Technologies Corp

Advanced Protein Technologies Corp.(APTech) is a biotechnology company whose business goal is process development and manufacturing products related to biopharmaceutical industry. APTech has a lot of experiences to develop process for pharmaceutical recombinant protein using our platform technology called ADpure System™ since its founding in 2001. We has also produced various kinds of Active Pharmaceutical Ingredients as well as protein materials in pharmaceutical process and other biotechnology. Based on that, APTech has participated actively in both domestic and international business fields. APTech is exerting all possible efforts to materialize its core technology of manufacturing high quality protein with high productivity, which has been steadily demanding from the areas of medicine, food and cosmetic industry.

11 to 50 staff

Medimabbio

MediMabBio is a ground-breaking biotherapeutic company focusing on the generation of novel immunotherapies for the treatment of cancer. Our discovery platform uses advances in systems biology combined with sophisticated immunological solutions to identify significantly improved first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumors. The company has developed a pipeline of highly promising novel drugs that aims to overcome the current limitations of cancer immunotherapy. For this purpose, MediMabBio has established collaborations with core partners of academic, R&D institutions and clinical groups in US, UK, Germany, China and Korea.

11 to 50 staff

Caregen Co. Ltd

Caregen, a global leader in peptide research and development, is a global biotechnology company that has commercialized the unlimited expandability of its patented peptides as many innovative products since its establishment in 2001. Over 600 different functional peptides developed by Caregen for the past 19 years have opened new paradigm in the field of biotechnology by expanding its applications to cosmeceutical, Class medical devices, food supplement, and pharmaceuticals. We are striving to dramatically improve human life and health providing total health care solution through the development, production, and supply of various peptides. Our innovative peptide-based products provide solutions to many people around the world who are pursuing health and beauty with our unique skin delivery technology that maximize the efficacy and effectiveness of products Global leader in Peptide Research and development: Peptide-based products developed by Caregen provide total health care solutions across all areas of the anti-aging industry. By combining unique skin delivery technology, Caregen provides a variety of safe and highly effective cosmeceuticals and medical device products to 130 countries around the world. Caregen’s research goes beyond biomimetic peptide research and maximize the efficacy of biomimetic peptides with a new approach to hybrid peptides. We are expanding these hybrid peptides into a pharmaceutical product with optimal efficacy and safety Innovative R&D: One of the most important features that can define Caregen’s product development capabilities is a product with a variety of functions that are safe and effective for maximum use all based on our various patented peptides. In particular, PTx, which has the world’s first Botulinum Toxin Type C mechanism, provides innovative solutions to many people around the world as its application extending to management of hyperhidrosis, pain, and skin diseases by topical use.

201 to 500 staff

Genuv

Founded in 2016 in South Korea, Genuv() is a clinical-stage biopharma that specializes in discovering and developing innovative therapeutics based on own platform technologies for drug discovery. GENUV is dedicated to the discovery and development of life-transforming therapeutics for patients with debilitating diseases. To do this, we passionately endeavor to advance our own platform technologies and capitalize on our strengths in multi-disciplinary collaborations with external partners. Our current research and development focus is on a) small molecule drugs to treat neurodegenerative diseases through neurogenesis and neural homeostasis and b) antibody drugs for immuno-oncology treatment.

11 to 50 staff

Kangstem Biotech Co., Ltd

Kangstem Biotech was established to develop stem cell therapeutic products for rare and incurable diseases. Our Business [Stem Cell Therapy] Kangstem Biotech has developed the technology to isolate the non hematological system stem cell with multi conversion and high purity from the cord blood and to culture large quantity; and has developed the Furestem® for the stem cell therapy to cure the incurable diseases.(Atopic Dermatitis, Rheumatoid Arthritis, Osteoarthritis)[Stem Cell Conditioned Media] USC-CM (Umbilical cord blood-derived Stem Cell Conditioned Media) is obtained from our patented stem cell culture process. It was proved that it contains plenty of growth factors secreted by differentiating stem cells.[Stem Cell Culture Media] The stem cell conditioned medium (KSB-3 Complete Medium® Kit) of Kangstem Biotech is a medium for culturing the human mesenchymal stem cell, which can enhance the proliferation of stem cells in a state of non conversion and provide with the high proliferation ability and uniform cell state at culturing.[Cell Freezing and Thawing Platform] CryoSupport is a platform for Cellfreezing and Thawing [CDMO] we promise to do our best to support your project as a "Super Supporter"-Contract Manufacturing Organization(CMO)-Contract Development Organization(CDO)[Health & Beauty(H&B) Business] GD11 is a cell bio-derma cosmetic brand that embodies real visual effects on the skin with international patented technology secured through cord blood stem cell research since 1994 and a proven ingredient in Human Cord Blood Cell Conditioned Media, USC 1994®. for more information visit our website

51 to 200 staff

Microbiotix Co., Ltd

Microbiota banking FMT 19.

11 to 50 staff

Hs Biosystems

We are based on connection and development for BIT to develop the Bio-infra instrument and reagents for using molecular diagnostics. Through the C&D technologies, we will lead the personnel optimized clinical diagnostic market by exact, convenient and competitable product. We must contribute for human well-being as a technology based bio-company which provides the best service and quality of goods.

1 to 10 staff

Noblekinmat Ltd

An impact Development company with the mandate of ‘leading a generation of impact, prosperity and sustainability’ among Africans in the area of Bioinformatics, Data Science, Health, Education, Media and Publicity. NOBLEKINMAT Ltd. is dedicated to leading the next frontier of Africa’s development in all spheres of the continents’ transformational plan through the digitalization and democratization of knowledge and skilled manpower. We are dedicated to building a strong workforce for companies, institutions and government agencies working towards that collective goal of creating a future for Africa and beyond. The company was founded officially in 2022 to create IMPACT, PROSPERITY and a SUSTAINABLE development through empowering, engaging and equipping people at all age grade and levels through the company’s platforms. At the end of the year 2022, we aim to raise and train a more than a million individual in every aspect of our Company’s mandate across Africa and beyond. We would fulfil this mandate by identifying opportunities at each level of societal strata through outreach to community leaders and organizations, and networking with the right donors/investors to achieve the desired goal.

11 to 50 staff

Kogenebiotech

KogeneBiotech is a leading company in the in-vitro diagnostics industry and has developed the 1st SARS-CoV-2 Real-time PCR Kit in South Korea, January 2020. We are a representative with a significant contribution in the early diagnosis and prevention of the spread of COVID-19 successfully. KogeneBiotech – the first mover of the Real-time PCR assay – has developed more than PCR Kits. As a result, we have established an extensive product portfolio in emerging diseases, clinical diagnostics, food safety, animal diseases, and pathogens. We strive to ensure and improve public healthcare while maintaining continuous cooperation with the government authorities, the national research institutes, the great hospitals, and medical centers.

51 to 200 staff

Nobo Medicine

We are a clinical-stage biotech company pioneering novel therapies for hematologic cancers and diseases linked to clonal hematopoiesis (CH)—a key driver of immune aging. Our lead program, granted Orphan Drug Designation by the Korean Ministry of Food and Drug Safety, is currently undergoing a pivotal clinical trial in Korea. We are driven by a sense of urgency and purpose to translate cutting-edge science into transformative treatments—bringing new hope to patients with limited options. For more information, please visit our website- Official Website: https://en.nobomedicine.com/

11 to 50 staff

Gradiant Bioconvergence

Gradiant Bioconvergence (GBCC) is a pioneer in the development of patient-derived cancer organoids (PDOs) on a global scale. We have established Asia’s largest PDO repository, comprising over 800 models from patients with lung, gastric, colorectal, pancreatic, and ovarian cancers, all characterized using next-generation sequencing. In parallel, we are advancing co-culture systems that integrate autologous immune cells and cancer-associated fibroblasts with our PDOs. Leveraging our comprehensive genomic, transcriptomic and drug response datasets, we are identifying and validating novel drug-resistant oncology targets through our AI-driven discovery engine and CRISPR-enabled PDO platform. Beyond oncology, GBCC is also developing brain organoids from human iPSCs to support drug evaluation, disease modeling and regenerative medicine applications.

11 to 50 staff

Imnewrun

IMNEWRUN creates breakthrough solutions for patients with brain diseases. Our focus includes novel, next-generation blood-brain barrier-penetrating antibodies. IMNEWRUN is a learning platform designed to spark innovation, where students, faculty, and industry experts interact closely to create exponential learning opportunities. We bring synergy to accelerate new scientific discoveries and to develop next-generation treatment modalities We are a team of passionate scientists and professionals who are committed to serving humanity through biotechnology. We are enthusiastic explorers in understanding fundamental science and creating a culture that inspires lives of many. We invite you to learn more about IMNEWRUN and how we are working to make a difference in the world.

11 to 50 staff

Inertia Inc

INERTIA is a Korean female engineer-based startup, founded at KAIST. We aim to be a pioneer in illuminating and resolving the discomfort of women with empathy and technology.

1 to 10 staff

Sp2tx

SP2 Therapeutics is redefining peptide synthesis, addressing core biopharmaceutical production challenges. Our patent-protected FLOWSMART system combines Nobel-prize winning solid phase peptide synthesis with AI-guided, resin-based flow chemistry, achieving massive cost savings and scalability. SP2 Therapeutics is a spinout from Seoul National University's renowned Institute of Molecular Biology and Genetics. Our core team’s expertise spans diverse domains such as resin-based chemistry, bioinformatics, engineering, and machine learning. Our FLOWSMART synthesis platform can greatly accelerate your peptide drug development efforts.

1 to 10 staff

Spl Life Sciences

SPL Life Sciences Co, Ltd. is a leading manufacturer/ exporter in scientific plastic lab-ware of Korea. Since established in 1987, we are dedicated to manufacture high quality plastic lab-ware, consistent to the finest standards in the industries. With a team of enthusiastic professionals continuously engaging in research, development and quality control, our products fully comply with the international regulatory requirements. For over three decades in the industry, we have gained enormous amount of knowledge and experiences. Our highly qualified and experienced personnel strive for their best to produce high quality products at competitive prices. Along with the dominant position in the domestic market, we have excelled in the international trade with customers in the United States, most countries in Europe and Asia. We are rapidly gaining international reputation by promptly developing most advanced products used in life science field. We, SPL Life Sciences, are committed to meet the needs of the customers on providing up-to-date life science technology. With active investments in the Research & Development, we now offer more innovative solutions in a wide range of life science applications.

51 to 200 staff

Cell Biotech Co., Ltd

Cell Biotech is a group of more than 300 microorganism specialists who focus their research entirely on probiotics only. Based on our world-patented dual coating technology, we have created a probiotic-specialized "One Stop Solution" to develop the best probiotic products with the aim of improving the intestinal health of people around the world. Cell Biotech is Korea’s leading probiotics company exporting to forty countries around the world and managing five brand businesses in South Korea, Denmark, France, Poland and Singapore. We have established partnerships with multinational companies and local retailers to distribute our products. With over two decades of probiotics business experience, we have localized our products to meet the needs of diverse cultures, ethnicities, regions, and climates.

201 to 500 staff

Seoulin Bioscience

SeouLin Bioscience'(SLB) is the total solutions provider in life sciences & healthcare since 1984. SLB aims to grow as a global leading bio company that provides differentiated service with the mission of customer success. We hold 15 local agencies that are being trained by SLB in every month to strengthen professionalism and over customer database in genomics, proteomics, cell biology, bioinformatics, and bioprocess. Based on our bio-industry sales experience, we have provided eco-friendly Hypochlorous acid(HOCl) generator ecoTreeTM to meet the customers' needs for sterilized water. From research laboratories to industrial fields, our new business has expanded to more than one hundred customer sites that requires the sterilization and sanitation.

51 to 200 staff

Therapex Co., Ltd

11 to 50 staff